Best Practice & Research Clinical Rheumatology
Volume 23, Issue 4 , Pages 575-582 , August 2009

Managing lupus patients during pregnancy

  • Guillermo Ruiz-Irastorza, MD, PhD, Doctor

      Affiliations

    • Service and Department of Internal Medicine, Hospital De Cruces, University of the Basque Country, Bizkaia, Spain
    • ,
  • Munther A. Khamashta, MD, FRCP, PhD, Doctor

      Affiliations

    • Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College, London SE1 7EH, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 20 7620 2567; Fax: +44 20 7620 26 58.

References 

  1. Clowse MEB, Jamison M, Myesr E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199:127.e1–127.e6
  2. Andrade RM, McGwin G, Alarcon GS, et al. Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII). Rheumatology. 2006;45:1380–1384
  3. Chakravarty EF, Colón I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192:1897–1904
  4. Andrade R, Sanchez ML, Alarcon GS, et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI). Clin Exp Rheumatol. 2008;26:268–274
  5. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus. 2008;17:416–420
  6. Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus. 2005;14:89–94
  7. Lima F, Khamashta MA, Buchanan NMM, et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol. 1996;14:131–136
  8. Ramsey-Goldman R, Kutzer JE, Kuller LH, et al. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol. 1993;138:1057–1069
  9. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol. 2003;101:1333–1344
  10. Mackillop LH, Germain SJ, Nelson-Piercy C. Systemic lupus erythematosus. Br Med J. 2007;335:933–936
  11. Opatrny L, David M, Kahn SR, et al. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol. 2006;33:2214–2221
  12. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827–1832
  13. Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum. 2001;44:1832–1835
  14. Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am. 2007;33:267–285
  15. Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus. 2006;15:148–155
  16. Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Heart disease, pregnancy and systemic autoimmune diseases. In:  Oakley C,  Warnes CA editor. Heart disease in pregnancy. 2nd edn.. Blackwell Publishing; 2007;p. 136–150
  17. Cuadrado MJ, Mendonça LLF, Khamashta MA, et al. Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia. Arthritis Rheum. 1999;42:S265
  18. Bonnin M, Mercier FJ, Sitbob , et al. Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology. 2005;102:1133–1137
  19. Papageorghiou AT, Roberts N. Uterine artery Doppler screening for adverse pregnancy outcome. Curr Opin Obstet Gynecol. 2005;17:584–590
  20. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford). 2006;45:332–338
  21. Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8:209–227
  22. Petri M. The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin North Am. 2007;33:27–35
  23. Ruiz-Irastorza G, Khamashta MA, Nelson-Piercy C, Hughes GRV. Lupus pregnancy: is heparin a risk factor for osteoporosis?. Lupus. 2001;10:597–600
  24. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and anticoagulation). Reg Anesth Pain Med. 2003;28:172–197
  25. Wetzl RG. Anesthesiological aspects of pregnancy in patients with rheumatic diseases. Lupus. 2004;13:699–702
  26. Nelson- Piercy C. Handbook of obstetric medicine. 3rd edn.. Informa Healthcare; 2006;
  27. The Canadian Hydroxychloroquine Study Group . A randomized study of the effect of withdrawing hydroxychloroquine sulphate in systemic lupus erythematosus. N Engl J Med. 1991;324:150–154
  28. Ruiz-Irastorza G, Egurbide M, Pijoan J, et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus. 2006;15:577–583
  29. Fessler B, Alarcón G, McGwin GJ, et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 2005;52:1473–1480
  30. Alarcón G, McGwin G, Bertoli A, et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007;66:1168–1172
  31. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta M. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2008 Dec 22. [Epub ahead of print].
  32. Clowse M, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54:3640–3647
  33. Levy R, Vilela V, Cataldo M, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus. 2001;10:401–404
  34. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 1991;34:1538–1545
  35. Ruiz-Irastorza G, Lima F, Alves J, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol. 1996;35:133–138
  36. Urowitz MB, Gladman DD, Farewell VT, et al. Lupus and pregnancy studies. Arthritis Rheum. 1993;36:1392–1397
  37. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol. 1997;36:772–777
  38. Clowse MEB, Magder LS, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52:514–521
  39. Buyon JP, Kalunian KC, Ramsey-Goldman R, et al. Assessing disease activity in SLE patients during pregnancy. Lupus. 1999;8:677–684
  40. Ruiz-Irastorza G, Khamashta MA, Gordon C, et al. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum. 2004;51:78–82
  41. Clowse M. Lupus activity in pregnancy. Rheum Dis Clin North Am. 2007;33:237–252
  42. Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. Br Med J. 2005;330:576–580
  43. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1791–1798
  44. Carmona F, Font J, Cervera R, et al. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol. 1999;83:137–142
  45. Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev. 2002;1:298–304
  46. Ruiz-Irastorza G, Khamashta MA. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci. 2005;1051:606–612
  47. Bates SM, Greer IA, Pabinger I, et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:844S–886S
  48. Empson M, Lassere M, Craig J, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005 18;(2):CD002859
  49. Khamashta MA, Ruiz-Irastorza G, Hughes GRV. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am. 1997;23:15–30

PII: S1521-6942(09)00045-X

doi: 10.1016/j.berh.2009.04.004

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 4 , Pages 575-582 , August 2009

Article Tools